New drug doubles Melanoma survival time

February 24, 2012 6:17:58 PM PST
There's an important new weapon in the fight against skin cancer.

It's a drug called Zelboraf.

A study found it can double the survival time of people with malignant melanoma, from eight months to 16 months.

The disease kills 9,000 people each year in the U.S.

It's usually fatal once it spreads.

Doctors say if you notice anything that's changed on your skin, have it checked immediately.

Get Eyewitness News Delivered

Facebook | Twitter | Newsletters | Text Alerts